Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan;114(1):20-23.
doi: 10.1007/s00347-016-0361-2.

[Epidemiology of myopia]

[Article in German]
Affiliations
Review

[Epidemiology of myopia]

[Article in German]
S Hopf et al. Ophthalmologe. 2017 Jan.

Abstract

Background: Myopia is the most common cause for impaired vision in children and young adults with increasing tendency. Although myopia is hereditary, genetic findings do not explain the full extent of its recent increase. Epidemiologic studies are required to investigate the prevalence and incidence of this disease.

Objectives: The prevalence, incidence and progression of myopia with its economic impact are emphasized to review the distribution and consequences of the development and progression of myopia.

Methods: A systematic literature search was conducted in MEDLINE.

Results: The global prevalence of myopia is currently 28.3 % and is dramatically increasing. In 2050, half of the world population will be affected. Myopia starts earlier and exhibits a peak prevalence in young Asian adults. High myopia indicates a similar development. Interventions to slow the development and progression of myopia are strongly required due to the medical and socio-economic drawbacks for the individuals and for society.

Conclusion: Myopia is already a ubiquitous phenomenon in some parts of the world. One out of ten persons will be at a relevant risk of becoming blind as a result of myopia in the future. Preventive measures have not shown sweeping success.

Keywords: Ametropia; Incidence; Prevalence; Progression; Vision disorders.

PubMed Disclaimer

References

    1. Clin Exp Optom. 2015 Nov;98 (6):497-506 - PubMed
    1. Int J Med Sci. 2015 Jul 25;12(8):633-8 - PubMed
    1. Lancet. 2012 May 5;379(9827):1739-48 - PubMed
    1. Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2903-10 - PubMed
    1. Br J Ophthalmol. 2014 Jul;98(7):857-61 - PubMed

LinkOut - more resources